-
Je něco špatně v tomto záznamu ?
The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis
K. Kubova, D. Peček, K. Hasserová, P. Doležel, M. Pavelková, J. Vyslouzil, J. Muselík, D. Vetchy,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- antikonvulziva aplikace a dávkování chemie MeSH
- celulosa chemie MeSH
- deriváty hypromelózy chemie MeSH
- kyseliny polymethakrylové chemie MeSH
- léky s prodlouženým účinkem chemie MeSH
- multivariační analýza MeSH
- piracetam aplikace a dávkování analogy a deriváty chemie MeSH
- příprava léků metody MeSH
- rozpustnost MeSH
- tablety MeSH
- teplota MeSH
- uvolňování léčiv MeSH
- Publikační typ
- časopisecké články MeSH
Hypromellose matrices exhibit extended burst effect immediately after contact with aqueous medium, especially when a water-soluble drug is incorporated. The objective of this study was to reduce burst effect and maintain complete dissolution of a very soluble levetiracetam over 12 h period from hypromellose K4M matrices to obtain zero-order kinetics. Desired changes were achieved by applying water dispersions of insoluble Eudragits(®) (NE, NM, RL, RS) as a granulation liquid to the drug/microcrystalline cellulose mixture during high-shear granulation (non-thermal treated set) and consequently by thermally treating granules or final tablets (TT), respectively. Applying Eudragit(®) water dispersions to the drug/microcrystalline cellulose mixture was recognized as an effective method of significantly reducing the burst release (25.4-33.7%) of levetiracetam in comparison with a reference sample without Eudragit(®). Multivariate data analysis showed that the addition of Eudragit(®) reduced burst effect, increased fitting with zero-order kinetics, and supported matrix erosion as the supplementary mechanism to predominant diffusion. Moreover, resulting PCA sub-model revealed the addition of Eudragit(®) RL and thermal treatment of tablets to be the most suitable method of all. For a 12 h dissolution profile, characterized by low burst effect and drug release close to 100% at the 12th hour, sample RL_TT was the most suitable.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013314
- 003
- CZ-PrNML
- 005
- 20170427100140.0
- 007
- ta
- 008
- 170413s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/10837450.2016.1193191 $2 doi
- 035 __
- $a (PubMed)28058866
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kubova, Katerina $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
- 245 14
- $a The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis / $c K. Kubova, D. Peček, K. Hasserová, P. Doležel, M. Pavelková, J. Vyslouzil, J. Muselík, D. Vetchy,
- 520 9_
- $a Hypromellose matrices exhibit extended burst effect immediately after contact with aqueous medium, especially when a water-soluble drug is incorporated. The objective of this study was to reduce burst effect and maintain complete dissolution of a very soluble levetiracetam over 12 h period from hypromellose K4M matrices to obtain zero-order kinetics. Desired changes were achieved by applying water dispersions of insoluble Eudragits(®) (NE, NM, RL, RS) as a granulation liquid to the drug/microcrystalline cellulose mixture during high-shear granulation (non-thermal treated set) and consequently by thermally treating granules or final tablets (TT), respectively. Applying Eudragit(®) water dispersions to the drug/microcrystalline cellulose mixture was recognized as an effective method of significantly reducing the burst release (25.4-33.7%) of levetiracetam in comparison with a reference sample without Eudragit(®). Multivariate data analysis showed that the addition of Eudragit(®) reduced burst effect, increased fitting with zero-order kinetics, and supported matrix erosion as the supplementary mechanism to predominant diffusion. Moreover, resulting PCA sub-model revealed the addition of Eudragit(®) RL and thermal treatment of tablets to be the most suitable method of all. For a 12 h dissolution profile, characterized by low burst effect and drug release close to 100% at the 12th hour, sample RL_TT was the most suitable.
- 650 _2
- $a antikonvulziva $x aplikace a dávkování $x chemie $7 D000927
- 650 _2
- $a celulosa $x chemie $7 D002482
- 650 _2
- $a léky s prodlouženým účinkem $x chemie $7 D003692
- 650 _2
- $a příprava léků $x metody $7 D004339
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a deriváty hypromelózy $x chemie $7 D065347
- 650 _2
- $a multivariační analýza $7 D015999
- 650 _2
- $a piracetam $x aplikace a dávkování $x analogy a deriváty $x chemie $7 D010889
- 650 _2
- $a kyseliny polymethakrylové $x chemie $7 D011109
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a tablety $7 D013607
- 650 _2
- $a teplota $7 D013696
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Peček, Daniel $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
- 700 1_
- $a Hasserová, Kristýna $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
- 700 1_
- $a Doležel, Petr $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
- 700 1_
- $a Pavelková, Miroslava $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
- 700 1_
- $a Vyslouzil, Jakub $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
- 700 1_
- $a Muselík, Jan $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
- 700 1_
- $a Vetchy, David $u a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences Brno , Brno , Czech Republic.
- 773 0_
- $w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 22, č. 2 (2017), s. 206-217
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28058866 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170427100500 $b ABA008
- 999 __
- $a ok $b bmc $g 1199779 $s 974092
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 22 $c 2 $d 206-217 $e 20170106 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
- LZP __
- $a Pubmed-20170413